Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

 161.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 163.50
  • 52 Week Low: 101.00
  • Currency: UK Pounds
  • Shares Issued: 106.69m
  • Volume: 30,263
  • Market Cap: £171.77m
  • RiskGrade: 352

Cello back in profit

Date: Tuesday 14 Sep 2010

LONDON (ShareCast) - Market research and consulting group Cello returned to the black in the half year and it remains confident for the full year.

"We are now seeing a pick up from our clients in the private sector across a range of industries and we are benefiting from our strong long term relationships and international research capabilities, particularly in the pharmaceutical sector," said chief executive Mark Scott.

The group reported a pre-tax profit of £2.6m for the six month period to 30 June 2010 compared to a loss of £3.8m the year before. Revenue increased to £61.5m from £55.4m before.

2010 has seen a solid recovery of existing client activity following the down turn in 2009, Scott added. The group is confident it will enter 2011 in 'robust financial health.'

"There has also been a strong flow of new business from existing clients and new client wins which have outweighed weakness in public sector income," Cello explained.

The interim dividend has been lifted 5% to 0.525p.



Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 161.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 163.50
52 Week Low 101.00
Volume 30,263
Shares Issued 106.69m
Market Cap £171.77m
RiskGrade 352

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
86.02% below the market average86.02% below the market average86.02% below the market average86.02% below the market average86.02% below the market average
Sector averageSector averageSector averageSector averageSector average
Price Trend
81.60% above the market average81.60% above the market average81.60% above the market average81.60% above the market average81.60% above the market average
53.85% above the sector average53.85% above the sector average53.85% above the sector average53.85% above the sector average53.85% above the sector average
Income
76.62% below the market average76.62% below the market average76.62% below the market average76.62% below the market average76.62% below the market average
38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average
Growth
30.41% below the market average30.41% below the market average30.41% below the market average30.41% below the market average30.41% below the market average
47.06% below the sector average47.06% below the sector average47.06% below the sector average47.06% below the sector average47.06% below the sector average

What The Brokers Say

Strong Buy 0
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 1
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  2nd Interim Interim
Ex-Div 23-Apr-20 03-Oct-19
Paid 22-May-20 01-Nov-19
Amount 1.00p 1.15p

Trades for 07-Aug-2020

Time Volume / Share Price
16:30 618 @ 160.00p
16:03 11,000 @ 160.00p
16:01 8,003 @ 160.00p
15:21 310 @ 160.00p
15:19 8,000 @ 160.00p

Cello Health Key Personnel

CEO Mark Scott

Top of Page